[go: up one dir, main page]

BR9810280A - Proliposome powders for inhalation established by tocopherol. - Google Patents

Proliposome powders for inhalation established by tocopherol.

Info

Publication number
BR9810280A
BR9810280A BR9810280-0A BR9810280A BR9810280A BR 9810280 A BR9810280 A BR 9810280A BR 9810280 A BR9810280 A BR 9810280A BR 9810280 A BR9810280 A BR 9810280A
Authority
BR
Brazil
Prior art keywords
tocopherol
inhalation
established
powder
proliposome
Prior art date
Application number
BR9810280-0A
Other languages
Portuguese (pt)
Inventor
Katarina Bystroem
Per-Gunnar Nilsson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of BR9810280A publication Critical patent/BR9810280A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

<B>''PóS DE PROLIPOSSOMO PARA INALAçãO ESTABILIZADA POR TOCOFEROL''<D>. Um pó de poliprossomo é descrito, dito pó contendo numa fase única, partículas discretas que compreendem (1) um componente biologicamente ativo, (2) uma proporção estabilizada de tocoferol, e (3) um lipídio ou mistura de lipídios tendo uma temperatura de transição de fase, abaixo de 37 C. Um processo para preparação do pó e o uso farmacêutico do mesmo, também é descrito.<B> '' PROLIPOSOME POWERS FOR TOCOPHEROL STABILIZED INHALATION '' <D>. A polyprosome powder is described, said powder containing in a single phase, discrete particles comprising (1) a biologically active component, (2) a stabilized proportion of tocopherol, and (3) a lipid or mixture of lipids having a transition temperature phase, below 37 C. A process for preparing the powder and the pharmaceutical use of it, is also described.

BR9810280-0A 1997-06-27 1998-06-08 Proliposome powders for inhalation established by tocopherol. BR9810280A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88441997A 1997-06-27 1997-06-27
PCT/SE1998/001090 WO1999000111A1 (en) 1997-06-27 1998-06-08 Proliposome powders for inhalation stabilised by tocopherol

Publications (1)

Publication Number Publication Date
BR9810280A true BR9810280A (en) 2000-09-12

Family

ID=25384589

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810280-0A BR9810280A (en) 1997-06-27 1998-06-08 Proliposome powders for inhalation established by tocopherol.

Country Status (18)

Country Link
EP (1) EP1001749A1 (en)
JP (1) JP2002510311A (en)
KR (1) KR20010014163A (en)
CN (1) CN1260713A (en)
AU (1) AU729100B2 (en)
BR (1) BR9810280A (en)
CA (1) CA2295028A1 (en)
EE (1) EE9900601A (en)
HU (1) HUP0003207A3 (en)
ID (1) ID23192A (en)
IL (1) IL133478A0 (en)
IS (1) IS5304A (en)
NO (1) NO996439L (en)
NZ (1) NZ501672A (en)
PL (1) PL337723A1 (en)
SK (1) SK184899A3 (en)
TR (1) TR199903271T2 (en)
WO (1) WO1999000111A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1138311A1 (en) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
EP1138313A1 (en) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
EP1138310A1 (en) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
SI1888033T1 (en) * 2005-06-09 2014-06-30 Meda Ab Method and composition for treating inflammatory disorders
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
TR201809166T4 (en) * 2013-05-06 2018-07-23 Dsm Ip Assets Bv Vitamin E formulation in powder form.
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
CN105078963B (en) * 2015-09-29 2018-06-22 中山大学 Alpha-tocopherol is preparing the application in treating snail fever drug
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
EP3824296A4 (en) 2018-07-20 2022-04-27 Lipocine Inc. LIVER DISEASE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016882A1 (en) * 1990-05-08 1991-11-14 Liposome Technology, Inc. Direct spray-dried drug/lipid powder composition
SA95160463B1 (en) * 1994-12-22 2005-10-04 استرا أكتيبولاج powders for inhalation

Also Published As

Publication number Publication date
WO1999000111A1 (en) 1999-01-07
TR199903271T2 (en) 2000-08-21
NO996439D0 (en) 1999-12-23
NZ501672A (en) 2001-06-29
IS5304A (en) 1999-12-15
NO996439L (en) 2000-02-28
AU729100B2 (en) 2001-01-25
EP1001749A1 (en) 2000-05-24
CN1260713A (en) 2000-07-19
KR20010014163A (en) 2001-02-26
HUP0003207A3 (en) 2001-03-28
PL337723A1 (en) 2000-08-28
CA2295028A1 (en) 1999-01-07
SK184899A3 (en) 2000-05-16
HUP0003207A2 (en) 2001-02-28
EE9900601A (en) 2000-08-15
JP2002510311A (en) 2002-04-02
IL133478A0 (en) 2001-04-30
AU7945698A (en) 1999-01-19
ID23192A (en) 2000-03-23

Similar Documents

Publication Publication Date Title
BR9810280A (en) Proliposome powders for inhalation established by tocopherol.
BR9811249A (en) New formulation for inhalation; showing volumetric density, when poured, from 0.20 to 0.38g / ml, process for preparing formulation and using it
ES2194931T3 (en) PHARMACEUTICAL COMPOSITION CONTAINING PROLIPOSOMA POWDER, INTENDED FOR INHALATION.
GB8501015D0 (en) Drug
YU49279B (en) PROCEDURE FOR PREPARING PHARMACEUTICAL FORMULATION FOR OBTAINING MEDICINES FOR INHALATION USE
IL105945A (en) Dermatological preparation for assisting the transport of oxygen in the skin and its preparation
BR9609447A (en) Compound pharmaceutical formulation use of a compound and processes for preparing a compound and treating a condition where thrombin is required
BR9916587A (en) Apparatus and process for preparing crystalline particles of a substance, particle population, pharmaceutical composition and crystalline particles of 2,6-diamino-3- (2,3,5-trichlorophenyl) -pyrazine
BR9809328A (en) Process for preparing solid forms of drugs that can be used perorally with controlled release of active substance
ES548168A0 (en) PROCEDURE FOR PREPARING COMPOSITIONS FOR COSMETIC OR PHARMACEUTICAL USE BASED ON LIPIDIC SPHERULES CONTAINING A POLYAMIDE POLYMER.
BR9916829A (en) Pharmaceutical aerosol formulations containing fluoroalkanes, budesonide and formoterol
HUT50794A (en) Herbicides comprising substituted benztriazole derivatives as active ingredient and process for producing the active ingredients
AU4151099A (en) Cosmetic or dermopharmaceutical composition in the form of beads and methods forpreparing same
BR9808285A (en) Zinc-free insulin crystals, therapeutic powder formulation, process for preparing zinc-free insulin crystals, use of zinc-free crystals, and process for the treatment of diabetes mellitus
IL105944A (en) Phospholipid-containing cosmetic preparation and its production
BR9602922A (en) Composition stabilizing mixture use and process for the preparation of a polymer
ES2089497T3 (en) DERIVATIVES OF 23-OXA IN THE VITAMIN D SERIES, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AS WELL AS THEIR USE AS MEDICINES.
ES2149082B1 (en) NEW FORMULATION FOR INHALATION.
HUP9900365A2 (en) N-aryl-1,2,4-triazolin-5-on derivatives, preparation and use thereof, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients
MX14310A (en) PROCEDURE FOR THE PREPARATION OF NEW ANTIARRHYTHMIC AGENTS, PRODUCT OBTAINED AND PHARMACEUTICAL PREPARATION THAT INCLUDES IT.
BR9915215A (en) Pharmaceutical composition for modified insulin sensitizer release
AU4480889A (en) A pharmaceutical composition for rapid release of the active component comprising an orderred mixture and a surfactant
ATE234319T1 (en) GLYCOSYLATED GINKGOLIDE DERIVATIVES, THEIR USE AS MEDICINAL PRODUCTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
DZ2311A1 (en) Use of benzopyran derivatives and the like for the preparation of medicaments against degenerative diseases.
PT806202E (en) PHARMACEUTICAL COMPOSITION BASED ON LIPOFILAS MATRIXES STABILIZED FOR CONTROLLED LIBERATION OF ACTIVE PRINCIPLES

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A,8A E 9AANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.